# Sutro Biopharma, Inc.: Form 8-K, filed Mar 30, 2023

- Company: [Sutro Biopharma, Inc.](/companies/stro.md) (CIK 1382101)
- Form: 8-K
- Filed: 2023-03-30
- Accepted by EDGAR: Mar 30, 2023, 16:32 ET
- Period: 2023-03-30
- Accession: 0000950170-23-010978
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1382101/000095017023010978/stro-20230330.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1382101/000095017023010978/

## Items reported

- Item 2.02: Results of operations
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1382101/000095017023010978/stro-20230330.htm

Filed Mar 30, 2023.
Source: SEC EDGAR, the filing index for accession 0000950170-23-010978. Last ingested by Listed: Oct 24, 2026, 15:12 ET. No prices; not investment advice.